Page last updated: 2024-11-06

oxantel pamoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5281086
CHEBI ID93155
CHEBI ID7821
SCHEMBL ID601272
SCHEMBL ID17801965
MeSH IDM0112783

Synonyms (49)

Synonym
68813-55-8
oxantel pamoate
cp-14445-16
D00806
telopar (tn)
oxantel pamoate (usan)
telopar
HMS2093L04 ,
upy1d732t0 ,
nsc 759296
4,4'-methylenebis(3-hydroxy-2-naphthoic) acid, compound with (e)-3-(2-(1,4,5,6-tetrahydro-1-methylpyrimidin-2-yl)vinyl)phenol (1:1)
oxanel pamoate
unii-upy1d732t0
oxantel pamoate [usan]
phenol, 3-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)ethenyl), (e)-, 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1) (salt)
(e)-m-(2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)vinyl)phenol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1) (salt)
cp-14,445-16
cp 14,445-16
einecs 272-332-6
nsc-759296
nsc759296
pharmakon1600-01505982
S5722
SCHEMBL601272
oxantel pamoate [mi]
oxantel embonate [who-dd]
oxantel embonate [mart.]
CCG-213588
oxantel (pamoate)
HY-B1344
CS-5877
SCHEMBL17801965
AKOS026749864
CHEBI:93155
SR-05000001812-1
sr-05000001812
oxantel pamoate, analytical standard
CHEBI:7821
SBI-0206880.P001
4-[(3-carboxy-2-hydroxy-1-naphthalenyl)methyl]-3-hydroxy-2-naphthalenecarboxylic acid 3-[2-(1-methyl-5,6-dihydro-4h-pyrimidin-2-yl)ethenyl]phenol
Q27164876
68813-55-8 (pamoate)
(e)-3-(2-(1-methyl-1,4,5,6-tetrahydropyrimidin-2-yl)vinyl)phenol 4,4'-methylenebis(3-hydroxy-2-naphthoate)
3-[(e)-2-(1-methyl-5,6-dihydro-4h-pyrimidin-2-yl)ethenyl]phenol; embonic acid
AMY3614
NCGC00263960-01
Q27291192
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;3-[(e)-2-(1-methyl-5,6-dihydro-4h-pyrimidin-2-yl)ethenyl]phenol
BS-42477

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" About a fifth of the children reported adverse events, which were mainly mild."( Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled t
Albonico, M; Ali, SM; Alles, R; Ame, SM; Bogoch, II; Hattendorf, J; Huwyler, J; Keiser, J; Speich, B; Utzinger, J, 2015
)
0.42
" Oxantel pamoate was well tolerated across all treatment groups; only mild adverse events were reported by the participants 2 h (27 [10%]) and 24 h (12 [4%]) after treatment."( Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study.
Albonico, M; Ali, SM; Ame, SM; Hattendorf, J; Huwyler, J; Keiser, J; Moser, W; Puchkov, M; Speich, B, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
" Elevated plasma levels of albendazole sulfoxide, albendazole sulfone, and mebendazole in coadministrations are probably not mediated by CYP-based drug-drug interaction."( In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.
Cowan, N; Keiser, J; Vargas, M, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" The drug is metabolically stable, shows low permeability and low systemic bioavailability after oral use."( Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.
Chabicovsky, M; Gander-Meisterernst, I; Keiser, J; Palmeirim, MS; Scandale, I; Specht, S, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" fourth stage larvae (L4), pre-adult and adult stages were dosed with anthelminitics."( Response of pre-adult and adult stages of Trichuris muris to common anthelmintics in mice.
Bose, S; Deb, BN; Dhage, KR; Jones, MP; Rajasekariah, GR, 1991
)
0.28
" We aimed to assess the nature of the dose-response relation to determine the optimum dose."( Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study.
Albonico, M; Ali, SM; Ame, SM; Hattendorf, J; Huwyler, J; Keiser, J; Moser, W; Puchkov, M; Speich, B, 2016
)
0.43
"Tablets for oral suspension (TOS) present a convenient alternative dosage form to conventional tablets."( Stability investigation of FCC-based tablets for oral suspension with caffeine and oxantel pamoate as model drugs.
Huwyler, J; Puchkov, M; Schoelkopf, J; Wagner-Hattler, L, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphthoic acidAn aromatic carboxylic acid that consists of a naphthalene skeleton substituted by one or more carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (9.52)18.7374
1990's1 (4.76)18.2507
2000's0 (0.00)29.6817
2010's15 (71.43)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (28.57%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Different Drug Combinations Against Hookworm Infection in School-aged Children in the Lao People's Democratic Republic, a Single Blind, Randomised Controlled Trial [NCT03278431]Phase 4420 participants (Actual)Interventional2017-09-27Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]